Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.

Literature DB >> 8842494

Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.

Abstract

In this article we review the role of angiogenesis in bladder tumor development and its putative role in determining tumor progression and recurrence. The potential value of antiangiogenic therapy in the disease is also discussed.

Entities: Disease

Mesh：

Year: 1996 PMID： 8842494 DOI： 10.1007/bf00437475

Source DB: PubMed Journal: Cancer Metastasis Rev ISSN： 0167-7659 Impact factor: 9.264

79 in total

1. Scatter factor induces blood vessel formation in vivo.

Authors: D S Grant; H K Kleinman; I D Goldberg; M M Bhargava; B J Nickoloff; J L Kinsella; P Polverini; E M Rosen
Journal: Proc Natl Acad Sci U S A Date: 1993-03-01 Impact factor: 11.205

2. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Authors: K J Kim; B Li; J Winer; M Armanini; N Gillett; H S Phillips; N Ferrara
Journal: Nature Date: 1993-04-29 Impact factor: 49.962

3. VEGF/VPF: the angiogenesis factor found?

Authors: M Klagsbrun; S Soker
Journal: Curr Biol Date: 1993-10-01 Impact factor: 10.834

4. Genetic alterations in bladder cancer.

Authors: G Dalbagni; J Presti; V Reuter; W R Fair; C Cordon-Cardo
Journal: Lancet Date: 1993-08-21 Impact factor: 79.321

5. Two molecular pathways to transitional cell carcinoma of the bladder.

Authors: C H Spruck; P F Ohneseit; M Gonzalez-Zulueta; D Esrig; N Miyao; Y C Tsai; S P Lerner; C Schmütte; A S Yang; R Cote
Journal: Cancer Res Date: 1994-02-01 Impact factor: 12.701

6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

Authors: L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; D R Senger; H F Dvorak
Journal: Cancer Res Date: 1993-10-01 Impact factor: 12.701

7. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.

Authors: H Eda; K Fujimoto; S Watanabe; M Ura; A Hino; Y Tanaka; K Wada; H Ishitsuka
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333

8. Clonal origin of bladder cancer.

Authors: D Sidransky; P Frost; A Von Eschenbach; R Oyasu; A C Preisinger; B Vogelstein
Journal: N Engl J Med Date: 1992-03-12 Impact factor: 91.245

9. Muscle-invasive bladder cancer: does it arise de novo or from pre-existing superficial disease?

Authors: L H Newman; M Tannenbaum; M J Droller
Journal: Urology Date: 1988-07 Impact factor: 2.649

10. Midkine and pleiotrophin expression in normal and malignant breast tissue.

Authors: R I Garver; D M Radford; H Donis-Keller; M R Wick; P G Milner
Journal: Cancer Date: 1994-09-01 Impact factor: 6.860

5 in total

1. Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9.

Authors: Chen-Chen Feng; Qiang Ding; Yuan-Fang Zhang; Hao-Wen Jiang; Hui Wen; Pao-Hsun Wang; Zhong Wu
Journal: Int Urol Nephrol Date: 2010-09-17 Impact factor: 2.370